IP Library Granted Patent US 8,357,718
Granted Patent B2
US 8,357,718 · App. 12/068,237 · Granted Jan 22, 2013

Compounds and methods for the treatment or prevention of flavivirus infections

Inventors: Laval Chan Chun Kong (Kirkland, CA); Sanjoy Kumar Das (Laval, CA); Nghe Nguyen-Ba (LaPrairie, CA); Liliane Halab (Outremont, CA); Bettina Hamelin (Sillery, CA); Oswy Z. Pereira (Kirkland, CA); Carl Poisson (Montreal, CA); Melanie Proulx (Knowlton, CA); Thumkunta Jagadeeswar Reddy (St. Laurent, CA); Zhang Ming-Qiang (Kirkland, CA)
Assignee: Vertex Pharmaceuticals (Canada) Incorporated
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,357,718
App. No.
12/068,237
Granted
Jan 22, 2013
Kind
B2
Abstract

Compounds represented by formula: wherein X, Y and Z are as defined herein, pharmaceutically acceptable salts thereof, and related compounds, are suitable for use in treating or preventing a Flaviviridae viral infection in a host.

Claims (12)

1. A compound of the formula:

or a pharmaceutically acceptable salt thereof;

wherein;

Z is oxo-cyclohexyl, hydroxy-cyclohexyl, hydroxyimino-cyclohexyl, methoxyimino-cyclohexyl, methoxy-cyclohexyl, carboxy-cyclohexyl, or hydroxy-methyl-cyclohexyl;

Rf, Rg and Rh in each case are independently H or C 1-6 alkyl;

Y is phenyl, phenyl substituted by F, phenyl substituted by Cl, phenyl substituted by methoxy, phenyl substituted by cyano, phenyl disubstituted by F, or phenyl disubstituted by acetyl;

X is methyl-cyclohexyl or fluoro-methyl-cyclohexyl; and

m is 0.

2. A compound according to claim 1 , wherein Z is hydroxy-cyclohexyl, hydroxyimino-cyclohexyl, methoxyimino-cyclohexyl, methoxy-cyclohexyl, carboxy-cyclohexyl, or hydroxy-methyl-cyclohexyl.

3. A compound according to claim 1 , wherein Y is phenyl, 4-fluoro-phenyl, 3-fluoro-phenyl, 4-chloro-phenyl, 4-methoxy-phenyl, 4-cyano-phenyl, 3,4-difluoro-phenyl, or 4-acetyl-phenyl.

4. A compound according to claim 1 , wherein X is 4-methyl-cyclohexyl or 1-fluoro-4-methyl-cyclohexyl.

5. A compound according to claim 1 , wherein said compound is a sodium salt.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2011
From: SHIRE BIOCHEM INC.
To: VIROCHEM PHARMA INC.
Reel/Frame 025693/0012 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2011
From: KONG, LAVAL CHAN CHUN; DAS, SANJOY KUMAR; NGUYEN-BA, NGHE; HALAB, LILANE; HAMELIN, BETTINA; PEREIRA, OSWY Z.; POISSON, CARL; PROULX, MELANIE; REDDY, THUMKUNTA JAGADEESWAR; ZHANG, MING-QIANG
To: SHIRE BIOCHEM INC.
Reel/Frame 025630/0293 →
MERGER Recorded Nov 10, 2010
From: VIROCHEM PHARMA INC.
To: VERTEX PHARMACEUTICALS (CANADA) INCORPORATED
Reel/Frame 025343/0812 →
Continuity (3)
Continuation 10730272 · Dec 9, 2003
Provisional Application 60431964 · Dec 10, 2002
Related Publication 20080269481A1 · Oct 30, 2008